The Latest Cardiac and Vascular News
Christopher Horton brings nearly 30 years of experience in the medical device and technology industry HINGHAM, Mass., Sept. 7, 2021 /PRNewswire/ — XACT Robotics®, the developer of the world’s first and only hands-free robotic system for CT-guided percutaneous procedures, the XACT ACE™ Robotic System, today announced that Christopher Horton has joined the company as […]
Acquisition builds upon Abbott’s leading vascular portfolio, adding mechanical thrombectomy devices for treating patients with peripheral blood clots ABBOTT PARK, Ill., Sept. 2, 2021 /PRNewswire/ — Abbott (NYSE: ABT) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood […]
Vancouver, British Columbia–(Newsfile Corp. – September 2, 2021) – CVR Medical Corp. (TSXV: CVM) (OTC Pink: CRRVF) (“CVR Medical” or the “Company” or “we“) a Canadian listed and US based healthcare company in the medical device market is pleased to announce the appointment of Darren Day as Chief Executive Officer (CEO), effective […]
NEW YORK, Sept. 1, 2021 /PRNewswire/ — Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) (“CHAQ”), a special purpose acquisition company sponsored by Chardan Capital Markets (“Chardan”), today announced the results for the proposals considered and voted upon by its stockholders at its special meeting held on September 1, 2021 (the “Special Meeting”), regarding the proposed […]
alfapump® – Positive results from second interim analysis of POSEIDON pivotal study; awaiting FDA approval on POSEIDON pivotal study expansion alfapump® – FDA regulatory submission now expected in mid-2023 due to worldwide supply shortage of electronic components; European commercial activities and clinical studies unaffected alfapump DSR® – Strong top-line results from RED DESERT; interim results […]
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 31, 2021 it granted stock options to purchase an aggregate of 113,600 shares of common stock to 10 new employees, whose employment commenced in August 2021, as a material inducement to […]
The Series A was led by a major strategic investor along with a significant investment from ShangBay Capital as well as other investors. Laplace Interventional plans to use the funds raised from this round towards achieving its preclinical milestones. MINNEAPOLIS–(BUSINESS WIRE)–Minnesota based Laplace Interventional, a medical device company developing a […]
Company focusing on consumer revenue growth with reduced cost structure Pharmaceutical assets may be monetized through licensing or sale Other strategic alternatives under consideration Board of Directors restructured in connection with new strategy HONOLULU, Aug. 31, 2021 /PRNewswire/ — Cardax, Inc., announced today that it is refocusing its business strategy on its […]
BASKING RIDGE, N.J., Sept. 01, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced the appointment of Dr. Kristen K. Buck as the Company’s Chief Medical Officer (“CMO”). Dr. […]
SHENZHEN, China, Aug. 30, 2021 /PRNewswire/ — LifeTech Scientific Corporation (LifeTech, 01302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 interim results. Compared with the first half of 2020, LifeTech achieved an outstanding performance. The revenue was approximately RMB461.1 million, increased by approximately 68.9%, the […]
